Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

BACKGROUND Measuring disease and injury burden in populations requires a composite metric that captures both premature mortality and the prevalence and severity of ill-health. The 1990 Global Burden of Disease study proposed disability-adjusted life years (DALYs) to measure disease burden. No comprehensive update of disease burden worldwide incorporating a systematic reassessment of disease and injury-specific epidemiology has been done since the 1990 study. We aimed to calculate disease burden worldwide and for 21 regions for 1990, 2005, and 2010 with methods to enable meaningful comparisons over time. METHODS We calculated DALYs as the sum of years of life lost (YLLs) and years lived with disability (YLDs). DALYs were calculated for 291 causes, 20 age groups, both sexes, and for 187 countries, and aggregated to regional and global estimates of disease burden for three points in time with strictly comparable definitions and methods. YLLs were calculated from age-sex-country-time-specific estimates of mortality by cause, with death by standardised lost life expectancy at each age. YLDs were calculated as prevalence of 1160 disabling sequelae, by age, sex, and cause, and weighted by new disability weights for each health state. Neither YLLs nor YLDs were age-weighted or discounted. Uncertainty around cause-specific DALYs was calculated incorporating uncertainty in levels of all-cause mortality, cause-specific mortality, prevalence, and disability weights. FINDINGS Global DALYs remained stable from 1990 (2·503 billion) to 2010 (2·490 billion). Crude DALYs per 1000 decreased by 23% (472 per 1000 to 361 per 1000). An important shift has occurred in DALY composition with the contribution of deaths and disability among children (younger than 5 years of age) declining from 41% of global DALYs in 1990 to 25% in 2010. YLLs typically account for about half of disease burden in more developed regions (high-income Asia Pacific, western Europe, high-income North America, and Australasia), rising to over 80% of DALYs in sub-Saharan Africa. In 1990, 47% of DALYs worldwide were from communicable, maternal, neonatal, and nutritional disorders, 43% from non-communicable diseases, and 10% from injuries. By 2010, this had shifted to 35%, 54%, and 11%, respectively. Ischaemic heart disease was the leading cause of DALYs worldwide in 2010 (up from fourth rank in 1990, increasing by 29%), followed by lower respiratory infections (top rank in 1990; 44% decline in DALYs), stroke (fifth in 1990; 19% increase), diarrhoeal diseases (second in 1990; 51% decrease), and HIV/AIDS (33rd in 1990; 351% increase). Major depressive disorder increased from 15th to 11th rank (37% increase) and road injury from 12th to 10th rank (34% increase). Substantial heterogeneity exists in rankings of leading causes of disease burden among regions. INTERPRETATION Global disease burden has continued to shift away from communicable to non-communicable diseases and from premature death to years lived with disability. In sub-Saharan Africa, however, many communicable, maternal, neonatal, and nutritional disorders remain the dominant causes of disease burden. The rising burden from mental and behavioural disorders, musculoskeletal disorders, and diabetes will impose new challenges on health systems. Regional heterogeneity highlights the importance of understanding local burden of disease and setting goals and targets for the post-2015 agenda taking such patterns into account. Because of improved definitions, methods, and data, these results for 1990 and 2010 supersede all previously published Global Burden of Disease results.

Diário da Constituinte [gravação de vídeo] : [programa n. 291]

Na Comissão de Sistematização tem início a votação do título que trata da Organização dos Poderes e do Sistema de Governo. O primeiro capítulo trata do Poder Legislativo, exercido pela Câmara dos Deputados e Senado Federal. De acordo com o substitutivo, os deputados terão mandato de quatro anos, cada estado terá número proporcional a sua população que não poderá ser menor que oito ou maior que 80 deputados. A Comissão de Sistematização rejeitou a proposta do Deputado Paulo Delgado (PT-MG) que previa a extinção do Senado Federal. Os senadores terão mandato de oito anos e cada estado terá direito a três representantes. O Senador Nelson Carneiro (PMDB-RJ) informa que a soma das forças do Senado Federal e Câmara dos Deputados é imprescindível para o equilíbrio da Federação. A falta de acordo sobre emenda a favor do voto proporcional gera desentendimento entre os líderes partidários. A votação da emenda foi adiada. O Deputado Vivaldo Barbosa (PDT-RJ) explica que o voto proporcional é uma questão central para o sistema de governo. A Mesa da Comissão de Sistematização adota medida para transferir a votação direta para o Plenário, respeitando o projeto vigente. Começa votação dos artigos 54 e 55 que tratam das Atribuições do Congresso Nacional. Aprovada emenda do Deputado José Maria Eymael (PDC-SP), que pediu a supressão do inciso que dava ao Congresso competência para decretar o confisco de bens de quem enriquecer ilicitamente à custa do patrimônio público. O Deputado Brandão Monteiro (PDT-RJ) informa que a Comissão de Sistematização está dividida quanto à escolha do sistema de governo. Os Deputados Euclides Scalco (PMDB-PR) e Siqueira Campos (PDC-GO) comentam que a tendência da Comissão de Sistematização é votar pelo parlamentarismo. O Deputado Luís Inácio Lula da Silva (PT-SP) enfatiza que a votação do sistema de governo vai facilitar os trabalhos e acredita na vitória do presidencialismo.

超重核~(294)118和~(291)116及其α衰变链上各核素半衰期的研究

运用推广的液滴模型(GLDM)确定了超重核294118和291116及其α衰变链上各核素的衰变势垒,采用量子力学中的WKB方法计算α衰变中的势垒穿透几率,对该链上各原子核的α衰变半衰期进行了研究。此外,还利用Royer公式对该链上各原子核的α衰变半衰期进行了计算。结果表明,GLDM考虑亲和能与Royer公式给出的α衰变半衰期与超重核区的实验值符合很好,验证了GLDM和Royer公式在超重核区的适用性,可以用来预测超重核的半衰期。最后,预言了Z=118和116同位素链上各核素的半衰期,结果表明,在Z=118和116中存在α衰变长寿命同位素,这需要实验上的检验。

HST/STIS observations of the high-velocity interstellar cloud HVC 291.2-41.2+80: a warm, mainly ionized high-velocity cloud

We present intermediate-resolution HST/STIS spectra of a high- velocity interstellar cloud ((LSR)-L-upsilon = + 80 kms(-1)) towards DI1388, a young star in the Magellanic Bridge located between the Small and Large Magellanic Clouds. The STIS data have a signal-to-noise ratio (S/N) of 20-45 and a spectral resolution of about 6.5 km s(-1) (FWHM), The high-velocity cloud absorption is observed in the lines of C II, O I, Si II, Si III, Si IV and S III. Limits can be placed on the amount of S II and Fe II absorption that is present. An analysis of the relative abundances derived from the observed species, particularly C II and O I, suggests that this high-velocity gas is warm (T-k similar to 10(3)-10(4) K) and predominantly ionized, This hypothesis is supported by the presence of absorption produced by highly ionized species, such as Si IV, This sightline also intercepts two other high-velocity clouds that produce weak absorption features at (LSR)-L-upsilon = + 113 and + 130kms(-1) in the STIS spectra.

Traité d'anatomie humaine. Tome troisième, Système nerveux : méninges, moëlle, encéphale / A. Charpy. Embryologie / A. Prenant. Histologie / A. Nicolas ; 291 dessins originaux par M. A. Leuba

Comprend : Embryologie ; Histologie

HG 291.40-291.55 Thin Section

Coarse grained sample with inclusions of finer grained sediment. Clasts are small to large in size and angular to sub-rounded in shape. Grain crushing is abundant in this sample, and lineations and minor grain stacks can also be seen.

Genotoxic, mutagenic and cytotoxic effects of the commercial dye CI Disperse Blue 291 in the human hepatic cell line HepG2

Textile dyes are discarded into the aquatic ecosystem via industrial effluents and potentially expose humans and local biota to adverse effects. The commercial dye CI Disperse Blue 291 which contains the aminoazobenzene 2-[(2-bromo-4,6-dinitrophenyl)azo]-5(diethylamino)-4-methoxyacetanilide (CAS registry no. 56548-64-2), was tested for genotoxicity and cytotoxicity in the human hepatoma cell line HepG2, using the comet assay, micronucleus (MN) test and a cell viability test. Five different concentrations of the test compound were examined: 200 mu g/ml, 400 mu g/ml, 600 mu g/ml, 800 mu g/ml and 1000 mu g/ml. An increase in comet tail length and in the frequency of MN was detected with exposure of cells to concentrations of the commercial dye from 400 pg/ml. Furthermore, the dye was found to decrease cell viability. The results of this study demonstrate for the first time the genotoxic and mutagenic effects of the dye CI Disperse Blue 291 in mammalian cells, thus stressing the need to develop non-mutagenic dyes and to invest in improving the treatment of effluents. These measures will help to prevent harmful effects that these compounds can have on humans and aquatic organisms that come in contact with them. (C) 2007 Elsevier Ltd. All rights reserved.

Estudo da degradação do corante azo disperso azul 291 por cloração química e fotoeletroquímica

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Jornal da UNESP, 2013, ano XXVII, n. 291

Jornal elaborado pela Assessoria de Comunicação e Imprensa da Reitoria da UNESP

Minnie Lee Garrison Papers - Accession 291 - M124 (157-158)

The Minnie Lee Garrison Papers consist of genealogy materials relating to the Oates and Cherry families; letters and a poetry journal kept by Minnie Lee Garrison (1882-1942) while a student at Winthrop (Class of 1905); newspaper clippings concerning Ms. Garrison who was the first home extension agent in York County; survey or map of a tract of land in Rock Hill that was owned by a member of the Oates family; and other genealogical records.

Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients

The current gold-standard for diagnosing heparin-induced thrombocytopenia is the detection of platelet-activating antibodies by means of functional assays which, since they are time consuming and not widely available, are not suited to guiding acute treatment decisions. The objective of our study was to assess the ability of more rapid immunoassays to predict the presence of functionally relevant anti-platelet factor 4/heparin-antibodies.